STAT3 and Parkinson disease: Similar compounds show active in NCI ovarian cancer cell line (IGROV1), breast cancer cell line (MB-435); non small cell lung cancer (H23); MLPCN Alpha-synuclein 5'UTR binding activation (Parkinson's disease); Leishmania promastigote inhibition; NCI yeast anticancer screen; RAM inhibition (STAT3);